Your browser doesn't support javascript.
loading
Systematic Review of Available CAR-T Cell Trials around the World.
Barros, Luciana Rodrigues Carvalho; Couto, Samuel Campanelli Freitas; da Silva Santurio, Daniela; Paixão, Emanuelle Arantes; Cardoso, Fernanda; da Silva, Viviane Jennifer; Klinger, Paulo; Ribeiro, Paula do Amaral Costa; Rós, Felipe Augusto; Oliveira, Théo Gremen Mimary; Rego, Eduardo Magalhães; Ramos, Rodrigo Nalio; Rocha, Vanderson.
Affiliation
  • Barros LRC; Center for Translational Research in Oncology, Instituto do Câncer do Estado de Sao Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo 01246-000, Brazil.
  • Couto SCF; Fundação Pró-Sangue-Hemocentro de Sao Paulo, Sao Paulo 05403-000, Brazil.
  • da Silva Santurio D; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Departament of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo 01246-000, Brazil.
  • Paixão EA; Computational Modeling Department, National Laboratory of Scientific Computing, Petropolis 25651-075, Brazil.
  • Cardoso F; Graduate Program, National Laboratory of Scientific Computing, Petropolis 25651-075, Brazil.
  • da Silva VJ; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Departament of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo 01246-000, Brazil.
  • Klinger P; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
  • Ribeiro PDAC; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Departament of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo 01246-000, Brazil.
  • Rós FA; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Departament of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo 01246-000, Brazil.
  • Oliveira TGM; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Departament of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo 01246-000, Brazil.
  • Rego EM; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Departament of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo 01246-000, Brazil.
  • Ramos RN; Fundação Pró-Sangue-Hemocentro de Sao Paulo, Sao Paulo 05403-000, Brazil.
  • Rocha V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Departament of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo 01246-000, Brazil.
Cancers (Basel) ; 14(11)2022 May 27.
Article de En | MEDLINE | ID: mdl-35681646
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Systematic_reviews Langue: En Journal: Cancers (Basel) Année: 2022 Type de document: Article Pays d'affiliation: Brésil Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Systematic_reviews Langue: En Journal: Cancers (Basel) Année: 2022 Type de document: Article Pays d'affiliation: Brésil Pays de publication: Suisse